Etelcalcetide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB12865 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 50 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hyperphosphatemia (disease) | KG + DL |
| 2 | esophageal varices without bleeding | KG + DL |
| 3 | esophageal varices with bleeding | KG + DL |
| 4 | varicose disease | KG + DL |
| 5 | glaucoma | KG + DL |
| 6 | pancreatitis | KG + DL |
| 7 | primary hyperoxaluria | KG + DL |
| 8 | primary immunodeficiency syndrome due to p14 deficiency | KG + DL |
| 9 | severe congenital neutropenia | KG + DL |
| 10 | Barth syndrome | KG + DL |
| 11 | familial apolipoprotein C-II deficiency | KG + DL |
| 12 | autosomal recessive severe congenital neutropenia due to JAGN1 deficiency | KG + DL |
| 13 | cyclic hematopoiesis | KG + DL |
| 14 | Steel syndrome | KG + DL |
| 15 | familial hyperphosphatemic tumoral calcinosis/hyperphosphatemic hyperostosis syndrome | KG + DL |
| 16 | tumoral calcinosis, hyperphosphatemic, familial | KG + DL |
| 17 | autosomal recessive severe congenital neutropenia due to G6PC3 deficiency | KG + DL |
| 18 | autosomal recessive severe congenital neutropenia due to CSF3R deficiency | KG + DL |
| 19 | autosomal recessive severe congenital neutropenia due to CXCR2 deficiency | KG + DL |
| 20 | X-linked severe congenital neutropenia | KG + DL |
| 21 | congenital neutropenia-myelofibrosis-nephromegaly syndrome | KG + DL |
| 22 | constitutional megaloblastic anemia due to vitamin B12 metabolism disorder | KG + DL |
| 23 | hypophosphatasia | KG + DL |
| 24 | C1 inhibitor deficiency | KG + DL |
| 25 | lipase deficiency, combined | KG + DL |
| 26 | adult idiopathic neutropenia | KG + DL |
| 27 | growth hormone insensitivity syndrome with immune dysregulation 2, autosomal dominant | KG + DL |
| 28 | constitutional neutropenia | KG + DL |
| 29 | serpinopathy with toxic serpin polymerization | KG + DL |
| 30 | hereditary hypercarotenemia and vitamin A deficiency | KG + DL |
| 31 | Kostmann syndrome | KG + DL |
| 32 | pseudo-von Willebrand disease | KG + DL |
| 33 | alcoholic cardiomyopathy | KG + DL |
| 34 | Charcot-Marie-Tooth disease | KG + DL |
| 35 | Peyronie disease | KG + DL |
| 36 | isolated congenital growth hormone deficiency | KG + DL |
| 37 | primary release disorder of platelets | KG + DL |
| 38 | major hypertriglyceridemia | KG + DL |
| 39 | ptosis-strabismus-ectopic pupils syndrome | KG + DL |
| 40 | congenital Horner syndrome (disease) | KG + DL |
| 41 | ptosis-vocal cord paralysis syndrome | KG + DL |
| 42 | jaw-winking syndrome | KG + DL |
| 43 | pernicious anemia | KG + DL |
| 44 | Hurler syndrome | KG + DL |
| 45 | camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye | KG + DL |
| 46 | lipodystrophy-intellectual disability-deafness syndrome | KG + DL |
| 47 | Scott syndrome | KG + DL |
| 48 | MELAS syndrome | KG + DL |
| 49 | ptosis-upper ocular movement limitation-absence of lacrimal punctum syndrome | KG + DL |
| 50 | congenital entropion | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.